LYRA THERAPEUTICS INC
LYRA
LYRA was delisted on the 16th of March, 2026.
60 hedge funds and large institutions have $222M invested in LYRA THERAPEUTICS INC in 2023 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 21 increasing their positions, 3 reducing their positions, and 7 closing their positions.
4,600% more call options, than puts
Call options by funds: $1.27M | Put options by funds: $27K
600% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 3
229% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 7
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
78% more capital invested
Capital invested by funds: $125M → $222M (+$97.1M)
36% more funds holding
Funds holding: 44 → 60 (+16)
0.32% more ownership
Funds ownership: 1.29% → 1.61% (+0.32%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$10.9M |
| 2 |
VA
VR Adviser
New York
|
+$5.98M |
| 3 |
WP
Woodline Partners
San Francisco,
California
|
+$2.17M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$750K |
| 5 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$470K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$2.32M |
| 2 |
AC
Armistice Capital
New York
|
-$1.67M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$474K |
| 4 |
PGCM
Prescott Group Capital Management
Tulsa,
Oklahoma
|
-$117K |
| 5 |
VF
Virtu Financial
New York
|
-$77K |
LYRA Hedge Fund Activity: Q4 2023 in Review
60 of the 6,862 institutional investors tracked by Wall St. Rank reported a position in LYRA THERAPEUTICS INC (LYRA) for Q4 2023, worth a combined $222M — up 78% from $125M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new LYRA positions and 7 closed out — a net gain of 16 holders — while 21 added to existing stakes and 3 trimmed.
The largest buyer was Point72 Asset Management, opening a new position worth an estimated $10.9M. The largest seller was Soleus Capital Management, exiting entirely with an estimated $2.32M sold.
- 60 institutional investors held LYRA THERAPEUTICS INC (LYRA) as of Q4 2023, up from 44 in Q3 2023.
- Funds reported $222M of LYRA THERAPEUTICS INC stock for Q4 2023, up 78% quarter-over-quarter.
- 23 funds opened new LYRA THERAPEUTICS INC positions in Q4 2023 and 7 closed out, a net change of +16 holders.
- The largest LYRA THERAPEUTICS INC buyer in Q4 2023 was Point72 Asset Management, an estimated $10.9M added.
- The largest LYRA THERAPEUTICS INC seller in Q4 2023 was Soleus Capital Management, an estimated $2.32M sold.
Based on aggregated 13F filings for Q4 2023.